ArticleFrontiers in oncology2022

Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma.

Kshama Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.